Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $1.83 Million - $1.95 Million
34,147 New
34,147 $1.92 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $7,304 - $10,571
-227 Reduced 2.38%
9,321 $418,000
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $618 - $702
14 Added 0.15%
9,548 $434,000
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $62,286 - $131,493
1,955 Added 25.79%
9,534 $413,000
Q1 2023

May 12, 2023

SELL
$45.44 - $74.26 $1.01 Million - $1.66 Million
-22,307 Reduced 74.64%
7,579 $498,000
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $596,222 - $1.17 Million
14,405 Added 93.05%
29,886 $1.34 Million
Q3 2022

Nov 10, 2022

SELL
$72.36 - $113.1 $363,826 - $568,666
-5,028 Reduced 24.52%
15,481 $1.12 Million
Q2 2022

Aug 11, 2022

BUY
$87.2 - $114.05 $190,793 - $249,541
2,188 Added 11.94%
20,509 $2.2 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $884,067 - $1.17 Million
9,386 Added 105.05%
18,321 $2.03 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $176,007 - $204,711
-1,472 Reduced 14.14%
8,935 $1.14 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $355,675 - $463,776
3,258 Added 45.57%
10,407 $1.39 Million
Q2 2021

Aug 13, 2021

BUY
$100.34 - $115.69 $717,330 - $827,067
7,149 New
7,149 $773,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.